当前位置：
X-MOL 学术
›
Muscle Nerve
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis
Muscle & Nerve ( IF 3.4 ) Pub Date : 2021-09-10 , DOI: 10.1002/mus.27416 Nat Nasomyont 1 , Cuixia Tian 2 , Lindsey Hornung 3 , Jane Khoury 1, 3 , Paul M Hochwalt 4 , Joshua Cole Tilden 5 , Brenda L Wong 6 , Meilan M Rutter 1
Muscle & Nerve ( IF 3.4 ) Pub Date : 2021-09-10 , DOI: 10.1002/mus.27416 Nat Nasomyont 1 , Cuixia Tian 2 , Lindsey Hornung 3 , Jane Khoury 1, 3 , Paul M Hochwalt 4 , Joshua Cole Tilden 5 , Brenda L Wong 6 , Meilan M Rutter 1
Affiliation
Glucocorticoid-induced osteoporosis with vertebral fractures is frequent in patients with Duchenne muscular dystrophy (DMD). In this study, we evaluated the effects of oral bisphosphonate (BP) therapy on the prevalence and severity of vertebral fractures by vertebral morphometry assessment.
中文翻译：
口服双膦酸盐治疗对杜氏肌营养不良和糖皮质激素性骨质疏松症患者椎体形态测量和骨折的影响
糖皮质激素引起的伴有椎体骨折的骨质疏松症在 Duchenne 肌营养不良症 (DMD) 患者中很常见。在这项研究中，我们通过椎体形态测量评估口服双膦酸盐 (BP) 治疗对椎体骨折患病率和严重程度的影响。
更新日期：2021-11-16
中文翻译：
口服双膦酸盐治疗对杜氏肌营养不良和糖皮质激素性骨质疏松症患者椎体形态测量和骨折的影响
糖皮质激素引起的伴有椎体骨折的骨质疏松症在 Duchenne 肌营养不良症 (DMD) 患者中很常见。在这项研究中，我们通过椎体形态测量评估口服双膦酸盐 (BP) 治疗对椎体骨折患病率和严重程度的影响。
京公网安备 11010802027423号